Rosetta Genomics (ROSG) Closes 5.5M Offering at $5/Share
Rosetta Genomics Ltd. (Nasdaq: ROSG), announced the closing of an underwritten public offering of 5,500,000 ordinary shares at an offering price of $5.00 per share. The gross proceeds to Rosetta were $27.5 million, before deducting underwriting discounts and commissions and other offering expenses payable by Rosetta. In addition, Rosetta has granted the underwriter a 45-day option to purchase up to 825,000 additional ordinary shares to cover over-allotments, if any.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Western Gas Partners LP (WES) Prices 7.5M Common Offering at $70.85/Unit
- GT Advanced Technologies (GTATQ), Apple Lose Bid to Keep Declaration Under Seal - Bloomberg
- Chembio Diagn (CEMI) Reports DPP HIV 1/2 Assay Given CLIA Waiver From FDA